DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 181 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2018$10,627,000
+110.4%
109,117
+273.1%
0.42%
+134.8%
Q3 2018$5,052,000
-84.5%
29,249
-87.4%
0.18%
-84.2%
Q2 2018$32,513,000
+28.0%
233,000
+3.3%
1.14%
+29.8%
Q1 2018$25,402,000
-43.3%
225,452
-33.5%
0.88%
-50.1%
Q4 2017$44,775,000
+21.6%
339,180
-6.5%
1.76%
+6.3%
Q3 2017$36,813,000
+2.0%
362,724
+0.8%
1.66%
-13.9%
Q2 2017$36,088,000
-29.9%
359,983
-15.4%
1.92%
-3.0%
Q1 2017$51,465,000
-50.4%
425,545
-54.2%
1.98%
-53.5%
Q4 2016$103,725,000
-22.5%
928,192
-8.0%
4.27%
-31.4%
Q3 2016$133,855,000
+47.4%
1,008,475
+1.7%
6.22%
+74.4%
Q2 2016$90,819,000
+86.7%
991,800
+47.1%
3.57%
+72.2%
Q1 2016$48,656,000
+125.9%
674,373
+117.5%
2.07%
+137.3%
Q4 2015$21,535,000
-39.7%
310,122
-20.7%
0.87%
-36.8%
Q3 2015$35,737,000
-19.6%
391,122
+8.1%
1.38%
-6.7%
Q2 2015$44,462,000
+34.1%
361,953
-0.5%
1.48%
+37.9%
Q1 2015$33,144,000
+672.2%
363,700
+809.2%
1.07%
+520.8%
Q2 2014$4,292,00040,0000.17%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders